Contact:
sales@biotechnologyforums.com to feature here

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Diabetes: Symptoms, Treatment and Latest Research
#11
Intarcia Therapeutics Inc. has emerged with an implantable drug-delivery pump which is suggested to have been proved superior to currently existent Merck's Januvia drug.

Sized of a matchstick, this pump called ITCA 650, comes loaded with a whole year of supply of commonly used diabetes drug Exenatide.


Quote:ITCA 650 is implanted in abdominal tissue and can release the medicine continuously in minute quantities ensuring a steady state of medicine availability in the body and keeping the blood sugar levels in check.



The results have come post a year-long study involving 535 patients with Type 2 diabetes. Intarcia expects to publish the trial results in a journal and exhibit in medical meetings.
Sunil Nagpal
MS(Research) Scholar, IIT Delhi (Alumnus)
Advisor for the Biotech Students portal (BiotechStudents.com)
Computational Researcher in BioSciences at a leading MNC


Suggested Reads:
Top Biotech Companies | Top places to work
Indian Biotech Companies and Job Openings
Aiming a PhD in Top Grad School? | These are the Important Points to Consider
Careers in Biotechnology | A list of various Options
Biotechnology Competitive Exams in India
Like Post Reply
  


Messages In This Thread
Pump holding 1 year of Diabetes Drug to hit Market Soon - by SunilNagpal - 08-20-2015, 03:04 AM
Possibly Related Threads…
Thread
Author
  /  
Last Post
Replies: 0
Views: 5,919
12-16-2015, 12:27 AM
Last PostalekhyaGSP
Replies: 0
Views: 6,018
10-22-2015, 03:22 AM
Last Posthectorduvan89



Users browsing this thread:
1 Guest(s)

Diabetes: Symptoms, Treatment and Latest Research00